Loading
A phase 2 trial of zipalertinib in lung cancer, run by Stanford University, not yet recruiting.
Adjuvant ctDNA-Adapted Treatment With Zipalertinib in Early-Stage Atypical EGFR-Mutant NSCLC is a phase 2, interventional study registered as NCT07802834 by Stanford University, with a registry enrolment figure of 42 participants, started 2026-11 and due to reach its primary completion in 2028-12. Interventions recorded: Zipalertinib. Conditions listed: EGFR; Lung Cancer (NSCLC); Non Small Cell Lung Cancer. Primary outcome: Molecular response rate at 12 weeks. Lung eligibility wording from the registry: "Histological documentation of NSCLC (squamous histology is permitted)". No results are recorded here; the registry entry is the source.
Shares Zipalertinib, Resectable stage I to III non-small-cell lung cancer, EGFR-mutated non-small-cell lung cancer, Lung cancer trials open today (registry snapshot) and the tag lung-deep-dive.
Shares Resectable stage I to III non-small-cell lung cancer, EGFR-mutated non-small-cell lung cancer, MRD / molecular residual disease testing, Lung cancer trials open today (registry snapshot) and the tag lung-deep-dive.
Shares Resectable stage I to III non-small-cell lung cancer, MRD / molecular residual disease testing, Lung cancer trials open today (registry snapshot) and the tag lung-deep-dive.
Shares Resectable stage I to III non-small-cell lung cancer, EGFR-mutated non-small-cell lung cancer, Lung cancer trials open today (registry snapshot) and the tag lung-deep-dive.
Shares Resectable stage I to III non-small-cell lung cancer, Lung cancer trials open today (registry snapshot) and the tag lung-deep-dive.
Shares Resectable stage I to III non-small-cell lung cancer, Lung cancer trials open today (registry snapshot) and the tag lung-deep-dive.
Shares Resectable stage I to III non-small-cell lung cancer, Lung cancer trials open today (registry snapshot) and the tag lung-deep-dive.
Shares Resectable stage I to III non-small-cell lung cancer, Lung cancer trials open today (registry snapshot) and the tag lung-deep-dive.